Beersheba, Israel

Orna Kurlat

This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Orna Kurlat. Retrieved from https://idiyas.com/inventor/orna-kurlat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Orna Kurlat: Innovator in Pharmaceutical Chemistry

Introduction

Orna Kurlat is a prominent inventor based in Beer-Sheba, Israel. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. Her work is characterized by a focus on purity and efficacy in drug formulation.

Latest Patents

Orna Kurlat holds a patent for the "Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride." This invention provides a crystalline donepezil maleate, which serves as an intermediate in the preparation of donepezil hydrochloride. The patent also outlines novel processes for producing the compound in substantially pure form, as well as a method for creating pharmaceutically pure amorphous donepezil hydrochloride from it. She has 1 patent to her name.

Career Highlights

Kurlat's career is marked by her dedication to advancing pharmaceutical sciences. She has worked extensively on improving drug formulations to enhance their therapeutic effectiveness. Her innovative approaches have garnered attention in the scientific community.

Collaborations

Orna collaborates with notable colleagues, including Oded Arad and Lior Zelikovitch. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical research.

Conclusion

Orna Kurlat is a trailblazer in pharmaceutical innovation, with a focus on purity and efficacy in drug development. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…